Adam M. Brufsky, MD, PhD, University of Pittsburgh/UPMC Hillman Cancer Center

home / authors / adam-m-brufsky-md-phd-university-of-pittsburgh-upmc-hillman-cancer-center

Articles

Adam M. Brufsky, MD, PhD, FACP

Dr. Brufsky on the Efficacy of Enobosarm in ER+/AR+ Breast Cancer

Adam M. Brufsky, MD, PhD, University of Pittsburgh/UPMC Hillman Cancer Center
January 5th 2022

Adam M. Brufsky, MD, PhD, FACP, discusses efficacy data with enobosarm in metastatic estrogen receptor–positive, androgen receptor–positive, HER2-negative breast cancer.

Read More

Using Oral Therapies to Advance Care in MBC

Using Oral Therapies to Advance Care in MBC

Adam M. Brufsky, MD, PhD, University of Pittsburgh/UPMC Hillman Cancer Center;Lee S. Schwartzberg, MD, FACP, West Cancer Center & Research Institute;George W. Sledge Jr., MD, Stanford Cancer Center
February 16th 2021

Read More

Oral Therapies and Dose Reductions in MBC

Oral Therapies and Dose Reductions in MBC

Adam M. Brufsky, MD, PhD, University of Pittsburgh/UPMC Hillman Cancer Center;Lee S. Schwartzberg, MD, FACP, West Cancer Center & Research Institute;George W. Sledge Jr., MD, Stanford Cancer Center
February 16th 2021

Read More

MBC Therapy: Tesetaxel/Capecitabine

MBC Therapy: Tesetaxel/Capecitabine

Adam M. Brufsky, MD, PhD, University of Pittsburgh/UPMC Hillman Cancer Center;Lee S. Schwartzberg, MD, FACP, West Cancer Center & Research Institute;George W. Sledge Jr., MD, Stanford Cancer Center
February 16th 2021

Read More

Metastatic Breast Cancer Therapy: OPE

Metastatic Breast Cancer Therapy: OPE

Adam M. Brufsky, MD, PhD, University of Pittsburgh/UPMC Hillman Cancer Center;Lee S. Schwartzberg, MD, FACP, West Cancer Center & Research Institute;George W. Sledge Jr., MD, Stanford Cancer Center
February 9th 2021

Read More

At-Home Administration of Therapies to Treat MBC

At-Home Administration of Therapies to Treat MBC

Adam M. Brufsky, MD, PhD, University of Pittsburgh/UPMC Hillman Cancer Center;Lee S. Schwartzberg, MD, FACP, West Cancer Center & Research Institute;George W. Sledge Jr., MD, Stanford Cancer Center
February 9th 2021

Read More

Advantages of Oral Therapy for Metastatic Breast Cancer

Advantages of Oral Therapy for Metastatic Breast Cancer

Adam M. Brufsky, MD, PhD, University of Pittsburgh/UPMC Hillman Cancer Center;Lee S. Schwartzberg, MD, FACP, West Cancer Center & Research Institute;George W. Sledge Jr., MD, Stanford Cancer Center
February 2nd 2021

Read More

Chemotherapy to Treat MBC: Drug Developments

Chemotherapy to Treat MBC: Drug Developments

Adam M. Brufsky, MD, PhD, University of Pittsburgh/UPMC Hillman Cancer Center;Lee S. Schwartzberg, MD, FACP, West Cancer Center & Research Institute;George W. Sledge Jr., MD, Stanford Cancer Center
February 2nd 2021

Read More

Predicting Response to Chemotherapy in Metastatic Breast Cancer

Predicting Response to Chemotherapy in Metastatic Breast Cancer

Adam M. Brufsky, MD, PhD, University of Pittsburgh/UPMC Hillman Cancer Center;Lee S. Schwartzberg, MD, FACP, West Cancer Center & Research Institute;George W. Sledge Jr., MD, Stanford Cancer Center
January 26th 2021

Read More

Metastatic Breast Cancer: Chemotherapy Selection

Metastatic Breast Cancer: Chemotherapy Selection

Adam M. Brufsky, MD, PhD, University of Pittsburgh/UPMC Hillman Cancer Center;Lee S. Schwartzberg, MD, FACP, West Cancer Center & Research Institute;George W. Sledge Jr., MD, Stanford Cancer Center
January 26th 2021

Read More

Assessing Response to Chemotherapy in Metastatic Breast Cancer

Assessing Response to Chemotherapy in Metastatic Breast Cancer

Adam M. Brufsky, MD, PhD, University of Pittsburgh/UPMC Hillman Cancer Center;Lee S. Schwartzberg, MD, FACP, West Cancer Center & Research Institute;George W. Sledge Jr., MD, Stanford Cancer Center
January 19th 2021

Read More

Cytotoxic Chemotherapy for Metastatic Breast Cancer

Cytotoxic Chemotherapy for Metastatic Breast Cancer

Adam M. Brufsky, MD, PhD, University of Pittsburgh/UPMC Hillman Cancer Center;Lee S. Schwartzberg, MD, FACP, West Cancer Center & Research Institute;George W. Sledge Jr., MD, Stanford Cancer Center
January 19th 2021

Read More

Long-Term Disease Control in Metastatic Breast Cancer

Long-Term Disease Control in Metastatic Breast Cancer

Adam M. Brufsky, MD, PhD, University of Pittsburgh/UPMC Hillman Cancer Center;Lee S. Schwartzberg, MD, FACP, West Cancer Center & Research Institute;George W. Sledge Jr., MD, Stanford Cancer Center
January 19th 2021

Read More

Treatment Advances in Metastatic Breast Cancer

Treatment Advances in Metastatic Breast Cancer

Adam M. Brufsky, MD, PhD, University of Pittsburgh/UPMC Hillman Cancer Center;Lee S. Schwartzberg, MD, FACP, West Cancer Center & Research Institute;George W. Sledge Jr., MD, Stanford Cancer Center
January 19th 2021

Read More